IMMUNOLOGICAL AND BIOLOGICAL STABILITY OF IMMUNOTOXINS INVIVO AS STUDIED BY THE CLEARANCE OF DISULFIDE-LINKED POKEWEED ANTIVIRAL PROTEIN-ANTIBODY CONJUGATES FROM BLOOD
- 1 January 1985
- journal article
- research article
- Vol. 45 (5) , 2031-2036
Abstract
Monoclonal antibodies against human T-cell antigen 3A1, human transferrin receptor and mouse Thy 1. 1 antigen were linked to pokeweed antiviral protein (PAP) by a disulfide bond. Because the ability of the immunotoxin to home on target cells in vivo and the eventual internalization of the hemitoxin polypeptide depends in part on the stability of the conjugate in circulation, the clearance of antibody-PAP conjugates from blood was investigated. Blood samples collected from rabbits at different times after the injection of immunotoxin were analyzed for total mouse IgG and intact antibody-PAP conjugate in enzyme-linked immunosorbent assay. Further, antibody-PAP conjugate was separated from PAP by differential precipitation using polyethyleneglycol and the PAP content of the fractions were analyzed by radioimmunoassay. Free PAP was removed very rapidly from blood and 95% was cleared within 2 h. The immunotoxin did not dissociate in the circulation immediately and about 90% of the initial concentration of the conjugate was still present for > 4 h. Analysis by enzyme-linked immunosorbent assay showed a 4-8-h lag period in which immunotoxin concentrations were relatively unchanged. This was followed by a steady decline and the half-life of the conjugate in circulation then ranged between 17 and 24 h. Not only did the immunotoxins remain intact immunologically, but they also retained their biological activity as measured by the ability of blood-borne immunotoxins to efficiently block protein synthesis of target cells in vitro. The disulfide linkage of toxin to antibody is reasonably stable and the immunotoxin retains the biological properties of both the antibody and the hemitoxin polypeptide in circulation.This publication has 15 references indexed in Scilit:
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- MONOCLONAL ANTIBODY-RICIN A-CHAIN CONJUGATE SELECTIVELY CYTO-TOXIC FOR CELLS BEARING THE COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN1982
- Inhibition of mouse spleen cell function by diphtheria toxin fragment A coupled to anti-mouse Thy-1.2 and by ricin A chain coupled to anti-mouse IgMArchives of Biochemistry and Biophysics, 1981
- Cytotoxicity Acquired by Conjugation of an Anti‐Thy1.1 Monoclonal Antibody and the Ribosome‐Inactivating Protein, GeloninEuropean Journal of Biochemistry, 1981
- Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsNature, 1981
- CELL-SPECIFIC CYTO-TOXICITY EXPRESSED BY A CONJUGATE OF RICIN AND MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST THY 1.1 ANTIGEN1981
- Dynamic state of glutathione in blood plasma.Journal of Biological Chemistry, 1980
- Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.Proceedings of the National Academy of Sciences, 1980
- Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen.The Journal of Immunology, 1980
- Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.Proceedings of the National Academy of Sciences, 1979